Similar articles for PMID: 33813415

Year	Number of Results
1997	1
1998	1
2002	1
2004	1
2005	1
2008	2
2009	3
2010	1
2011	4
2012	2
2013	1
2014	1
2015	8
2016	11
2017	15
2018	17
2019	19
2020	10
2021	2
2022	0

1

Treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States.

Boczar D, Bagaria SP, Spaulding AC, Huayllani MT, Avila FR, Guliyeva G, Lu X, Rinker BD, Forte AJ. Boczar D, et al. Anticancer Res. 2021 Apr;41(4):2067-2070. doi: 10.21873/anticanres.14976. Anticancer Res. 2021. PMID: 33813415

2

Racial disparities and insurance status: An epidemiological analysis of Ohio melanoma patients.

Kooistra L, Chiang K, Dawes S, Gittleman H, Barnholtz-Sloan J, Bordeaux J. Kooistra L, et al. J Am Acad Dermatol. 2018 May;78(5):998-1000. doi: 10.1016/j.jaad.2017.11.019. Epub 2017 Nov 11. J Am Acad Dermatol. 2018. PMID: 29138060 No abstract available.

3

Disparities in the Presentation and Management of Cutaneous Melanoma That Required Admission.

Al-Qurayshi Z, Srivastav S, Wang A, Boh E, Hamner J, Hassan M, Kandil E. Al-Qurayshi Z, et al. Oncology. 2018;95(2):69-80. doi: 10.1159/000468152. Epub 2018 Jun 18. Oncology. 2018. PMID: 29913445

4

Socioeconomic status and survival for patients with melanoma in the United States: an NCDB analysis.

Sitenga JL, Aird G, Ahmed A, Walters R, Silberstein PT. Sitenga JL, et al. Int J Dermatol. 2018 Oct;57(10):1149-1156. doi: 10.1111/ijd.14026. Epub 2018 May 7. Int J Dermatol. 2018. PMID: 29736922

5

Hospital-Based Study of Compliance with NCCN Guidelines and Predictive Factors of Sentinel Lymph Node Biopsy in the Setting of Thin Melanoma Using the National Cancer Database.

Hayek SA, Munoz A, Dove JT, Hunsinger M, Arora T, Wild J, Shabahang M, Blansfield J. Hayek SA, et al. Am Surg. 2018 May 1;84(5):672-679. Am Surg. 2018. PMID: 29966567

6

Association of health insurance with outcomes in adults ages 18 to 64 years with melanoma in the United States.

Amini A, Rusthoven CG, Waxweiler TV, Jones BL, Fisher CM, Karam SD, Raben D. Amini A, et al. J Am Acad Dermatol. 2016 Feb;74(2):309-16. doi: 10.1016/j.jaad.2015.09.054. Epub 2015 Dec 6. J Am Acad Dermatol. 2016. PMID: 26670715

7

Reporting of mitotic rate in cutaneous melanoma: A study using the national cancer data base.

Lorimer PD, Benham EC, Walsh K, Han Y, Forster MR, Sarantou T, White RL Jr, Hill JS. Lorimer PD, et al. J Surg Oncol. 2017 Mar;115(3):281-286. doi: 10.1002/jso.24503. J Surg Oncol. 2017. PMID: 28335082

8

Treatment patterns, comorbidities, healthcare resource use, and associated costs by line of chemotherapy and level of comorbidity in patients with newly-diagnosed Merkel cell carcinoma in the United States.

Kearney M, Thokagevistk K, Boutmy E, Bharmal M. Kearney M, et al. J Med Econ. 2018 Dec;21(12):1159-1171. doi: 10.1080/13696998.2018.1517089. Epub 2018 Sep 12. J Med Econ. 2018. PMID: 30149739 Free article.

9

Racial and Socioeconomic Disparities in the Delivery of Immunotherapy for Metastatic Melanoma in the United States.

Haque W, Verma V, Butler EB, Teh BS. Haque W, et al. J Immunother. 2019 Jul/Aug;42(6):228-235. doi: 10.1097/CJI.0000000000000264. J Immunother. 2019. PMID: 30985445

10

Skin Cancer in Hispanics in the United States.

Perez MI. Perez MI. J Drugs Dermatol. 2019 Mar 1;18(3):s117-120. J Drugs Dermatol. 2019. PMID: 30909356

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed